![SI010191: Acalabrutinib Metabolite [AC-5862] label-new The trivalent presentation of GalNAcβ](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/SI010191.svg?v=1698329027)
Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The trivalent presentation of GalNAcβ residues engages multiple carbohydrate-recognition domains of ASGPR simultaneously
32 / / Micafungin-d11 Sodium salt / Mycamine-d11
C4H3D3N4O3S2 / 225
This compound enables the construction of hepatocyte-targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR
Synthetic DAG1(Man) glycopeptide
SI010191: Acalabrutinib Metabolite [AC-5862] label-new The trivalent presentation of GalNAcβC26H23N7O2 481. 53 Acalabrutinib Metabolite [AC 5862] AC 5862; 4 [8 Amino 3 [1 oxo 4 [(1 oxo 2 butyn 1 yl)amino]butyl]imidazo[1,5 a]pyrazin 1 yl] N 2 pyridinyl benzamide
US$ 282.50
US$ 36.85
US$ 24.02
US$ 33.99
US$ 36.85
US$ 254.50
US$ 124.50
US$ 1299.50
US$ 367.50
US$ 73.30
US$ 56.17
US$ 260.00
US$ 63.11
US$ 36.58
US$ 104.98
US$ 32.50
US$ 64.38
US$ 48.67
